Kunal Jobanputra

4PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersMolecular targetsAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 09, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.

|Dec 31, 2025
Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India.

Atul Tiwari, Ajay Kumar Singh, Vanita Noronha

|May 16, 2025
Cytomegalovirus infection in non-Hodgkin lymphoma: A case series.

Kunal Jobanputra, Rahul Ravind, Yashwant Kashyap

|Jan 27, 2023
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.

Vijay Maruti Patil, Vanita Noronha, Nandini Menon

Pageof 1

Frequent Collaborators

3 joint publications

Vanita Noronha

3 joint publications

Nandini Menon

2 joint publications

Archi Agrawal

2 joint publications

Minit Shah